IN8BIO, INC. (INAB)
↓ Download CSVKey ratios (FY2025)
-70.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$19.44M | -$30.44M | -$30.01M | -$28.52M | -$14.65M | -$8.56M | — |
| Net Income | -$19.44M | -$30.44M | -$30.01M | -$28.52M | -$14.65M | -$8.56M | — |
| EPS (Diluted) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | — | — |
| Total Assets | $32.28M | $20.94M | $33.71M | $33.04M | $42.22M | $20.91M | — |
| Total Liabilities | $4.72M | $6.47M | $8.77M | $10.31M | $4.04M | $2.59M | — |
| Shareholders' Equity | $27.56M | $14.48M | $24.94M | $22.73M | -$38.18M | -$16.58M | -$9.24M |
| Operating Cash Flow | -$12.71M | -$24.15M | -$23.34M | -$24.12M | -$13.51M | -$7.13M | — |
| Shares Outstanding | 9.77M | 2.42M | 43.29M | 24.55M | 18.78M | 3.76M | — |